Pharma Firm Cheers White House Psychedelic Order
April 20, 2026·about 3 hours ago·via Investing.com

Helus Pharma welcomes a White House order advancing psychedelic therapies, signaling smart policy to cut through FDA red tape and deliver real health innovations to Americans. This move champions individual liberty by exploring treatments big government long suppressed, aligning with America First skepticism of bureaucratic gatekeepers. Patients suffering from mental health crises deserve options beyond opioid traps and endless pills pushed by globalist lobbies. Read more about this...